Transforming growth factor-beta 2 is anterogradely and retrogradely transported in motoneurons and up-regulated after nerve injury

Neuroscience

Volumn 97, Issue 4, 2000, Pages 735-742

  Jiang, Y ^a   McLennan, I S ^a   Koishi, K ^a   Hendry, I A ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Australian National University   (Australia)

Author keywords

Axonal transport; Betaglycan; Schwann cells; Transforming growth factor beta; Transforming growth factor beta receptors

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; IMMUNOHISTOCHEMISTRY; MOTONEURON; NERVE FIBER TRANSPORT; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND MESSENGER;

ANIMALS; AXONAL TRANSPORT; BRAIN STEM; GENE EXPRESSION REGULATION; HYPOGLOSSAL NERVE; IMMUNOHISTOCHEMISTRY; MOTOR NEURONS; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; RATS; RATS, WISTAR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCIATIC NERVE; SPINAL CORD; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034037753     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00084-1     Document Type: Article

References (34)

1. Blottner D., Wolf N., Lachmund A., Flanders K.C., Unsicker K. TGF-beta rescues target-deprived preganglionic sympathetic neurons in the spinal cord. Eur. J. Neurosci. 8:1996;202-210.
2. Bottner M., Unsicker K., Suter-Crazzolara C. Expression of TGF-beta type II receptor mRNA in the CNS. NeuroReport. 7:1996;2903-2907.
3. Colosetti P., Olsson T., Miyazono K., Funa K. Axotomy of rat facial nerve induces TGF-beta and latent TGF-beta binding protein. Brain Res. Bull. 37:1995;561-567.
4. Crouch M.F., Heydon K., Garnaut S.M., Milburn P.J., Hendry I.A. Retrograde axonal transport of the alpha-subunit of the GTP-binding protein GZ in mouse sciatic nerve: a potential pathway for signal transduction in neurons. Eur. J. Neurosci. 6:1994;626-631.
5. Day W.A., McLennan I.S., Koishi K. TGF-β1-null-mutant mice have a de-myelinating disorder. Proc. Univ. Otago Med. School. 77:1999;18.
6. De Groot C.J., Montagne L., Barten A.D., Sminia P., Van Der Valk P. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J. Neuropath. exp. Neurol. 58:1999;174-187.
7. Diz D.I., Ferrario C.M. Bidirectional transport of angiotensin II binding sites in the vagus nerve. Hypertension. 11:1988;1139-1143.
8. Duclert A., Changeux J.-P. Acetylcholine receptor gene expression at the developing neuromuscular junction. Physiol. Rev. 75:1995;339-368.
9. Grafstein B. (1995) Axonal transport: Function and mechanisms. In The axon: structure, function, and pathophysiology (eds Waxman S. G. and Kocsis J. D. and Stys P. K.), pp. 185-199. Oxford University Press, New York.
10. Grimes M.L., Beattie E., Mobley W.C. A signaling organelle containing the nerve growth factor-activated receptor tyrosine kinase, TrkA. Proc. natn. Acad. Sci. U.S.A. 94:1997;9909-9914.
11. Guenard V., Gwynn L.A., Wood P.M. Transforming growth factor-beta blocks myelination but not ensheathment of axons by Schwann cells in vitro. J. Neurosci. 15:1995;419-428.
12. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simmons L.C., Moffet B., Vandlen R.A., Koliatsos V.E., Rosenthal A. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 266:1994;1062-1064.
13. Hendry I.A., Crouch M.F. Synergy, Retrograde Transport and Cell Death. 1993;Academic Press, New York.
14. Iseki S., Osumi-Yamashita N., Miyazono K., Franzen P., Ichijo H., Ohtani H., Hayashi Y., Eto K. Localization of transforming growth factor-beta type I and type II receptors in mouse development. Expl Cell Res. 219:1995;339-347.
15. Krieglstein K., Henheik P., Frakas L., Jaszai J., Galter D., Krohn K., Unsicker K. Glial cell line-derived neurotrophic factor requires transforming growth factor-β for exerting its full neurotrophic potential on peripheral and CNS neurons. J. Neurosci. 18:1998;9822-9834.
16. Krieglstein K., Unsicker K. Transforming growth factor-β promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridium ion toxicity. Neuroscience. 63:1994;1189-1196.
17. Lopez-Casillas F., Wrana J.L., Massague J. Betaglycan presents ligand to the TGF-β signaling receptor. Cell. 73:1993;1435-1444.
18. Martinou J.C., Levanthai A., Valette A., Weber M.J. Transforming growth factor-beta-1 is a potent survival factor for rat embryo motoneurons in culture. Devl Brain Res. 52:1990;175-181.
19. Mattson M.P., Keller J.N., Begley J.G. Evidence for synaptic apoptosis. Expl Neurol. 153:1998;35-48.
20. McLennan I.S., Koishi K. Transforming growth factor-beta-2 (TGF-β2) is associated with mature rat neuromuscular junctions. Neurosci. Lett. 177:1994;151-154.
21. McLennan I.S., Koishi K. Cellular localisation of transforming growth factor-beta 2 and -beta 3 (TGF-β2, TGF-β3) in damaged and regenerating skeletal muscles. Dev. Dyn. 208:1997;278-289.
22. McLennan I.S., Koishi K., Zhang M., Murakami N. The non-synaptic expression of transforming growth factor-beta 2 is neurally regulated and varies between skeletal muscle fibre types. Neuroscience. 87:1998;845-853.
23. Murakami N., McLennan I.S., Nonaka I., Koishi K., Baker C., Hammond-Tooke G. Transforming growth factor-β2 is elevated in skeletal muscular disorders. Muscle Nerve. 22:1999;889-898.
24. O'Reilly P.M., FitzGerald M.J. Fibre composition of the hypoglossal nerve in the rat. J. Anat. 172:1990;227-243.
25. Oppenheim R.W. Neurotrophic survival molecules for motoneurons: an embarrassment of riches. Neuron. 17:1996;195-197.
26. Pelton R.W., Saxena B., Jones M., Moses H.L., Gold L.I. Immunohistochemical localization of TGFbeta1, TGFbeta2, and TGFbeta3 in the mouse embryo - expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115:1991;1091-1105.
27. Roberts A. B. and Sporn M. B. (1990) The transforming growth factor-βs. In Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors (eds Sporn M. B. and Roberts A. B.), pp. 419-472. Springer-Verlag, Berlin.
28. Rufer M., Flanders K., Unsicker K. Presence and regulation of transforming growth factor beta mRNA and protein in the normal and lesioned rat sciatic nerve. J. Neurosci. Res. 39:1994;412-423.
29. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., Doetschman T. TGF beta2 knockout mice have multiple developmental defects that are non-overlapping with other TGF beta knockout phenotypes. Development. 124:1997;2659-2670.
30. Scherer S.S., Kamholz J., Jakowlew S.B. Axons modulate the expression of transforming growth-factor-betas in Schwann cells. Glia. 8:1993;265-276.
31. Stefansson K., Wollmann R.L., Moore B.W. Distribution of S-100 protein outside the central nervous system. Brain Res. 234:1982;309-317.
32. Stewart H.J.S., Cutis R., Jessen K.R., Mirsky R. TGF-bs and cAMP regulate GAP-43 expression in Schwann cells and reveal the association of this protein with the trans-Golgi network. Eur. J. Neurosci. 7:1995;1761-1772.
33. Unsicker K., Flanders K.C., Cissel D.S., Lafyatis R., Sporn M.B. Transforming growth factor-beta isoforms in the adult rat central and peripheral nervous system. Neuroscience. 44:1991;613-625.
34. Wrana J.L., Attisano I., Carcamo J., Zentella A., Doody J., Laiho M., Wang X.-F., Massague J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell. 71:1992;1003-1014.